Covered recipient · General Payments record
MALINI KANCHARLA REDDY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,642.55
- Reported across 163 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $628.18 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $257.44 | 15 |
| Amgen Inc. | $80.78 | 4 |
| Philips Electronics North America Corporation | $50.30 | 3 |
| Astellas Pharma US Inc | $37.43 | 2 |
| Novo Nordisk AS | $36.99 | 2 |
| GlaxoSmithKline, LLC. | $36.93 | 2 |
| Acerta Pharma LLC | $30.79 | 2 |
| Saluda Medical Americas, Inc. | $24.64 | 1 |
| DEXCOM, INC. | $21.38 | 1 |
| Paratek Pharmaceuticals, Inc. | $17.41 | 1 |
| Lilly USA, LLC | $17.20 | 1 |
| Merck Sharp & Dohme Corporation | $16.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $4.97 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928473 | CMS |
| ABBVIE INC. | $31.59 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928475 | CMS |
| ABBVIE INC. | $2.35 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928477 | CMS |
| ABBVIE INC. | $36.36 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928479 | CMS |
| ABBVIE INC. | $26.17 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928481 | CMS |
| ABBVIE INC. | $1.49 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928483 | CMS |
| ABBVIE INC. | $29.12 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928485 | CMS |
| ABBVIE INC. | $11.37 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928487 | CMS |
| ABBVIE INC. | $1.79 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928489 | CMS |
| ABBVIE INC. | $25.93 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928491 | CMS |
| ABBVIE INC. | $17.36 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928493 | CMS |
| ABBVIE INC. | $16.76 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928495 | CMS |
| ABBVIE INC. | $29.50 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928497 | CMS |
| ABBVIE INC. | $3.38 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928499 | CMS |
| ABBVIE INC. | $19.30 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105928501 | CMS |
| Amgen Inc. | $19.26 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117362080 | CMS |
| Amgen Inc. | $22.85 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117362082 | CMS |
| Amgen Inc. | $24.07 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117362084 | CMS |
| Amgen Inc. | $14.60 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117362086 | CMS |
| Astellas Pharma US Inc | $19.45 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139293108 | CMS |
| Astellas Pharma US Inc | $17.98 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139340256 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.67 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104513160 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.12 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105812671 | CMS |
| Dexcom, Inc. | $21.38 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153318412 | CMS |
| GlaxoSmithKline, LLC. | $18.89 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115893463 | CMS |
| GlaxoSmithKline, LLC. | $18.04 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116400614 | CMS |
| Lilly USA, LLC | $17.20 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135148094 | CMS |
| Merck Sharp & Dohme LLC | $16.89 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141570492 | CMS |
| Novo Nordisk Inc | $18.90 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097779169 | CMS |
| Novo Nordisk Inc | $18.09 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096714711 | CMS |
| Paratek Pharmaceuticals, Inc. | $17.41 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113915495 | CMS |
| Philips North America LLC | $23.00 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146872560 | CMS |
| Philips North America LLC | $13.72 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146872556 | CMS |
| Philips North America LLC | $13.58 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146872558 | CMS |
| Saluda Medical Americas, Inc. | $24.64 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081875210 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.